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Objectives
Serrated polyposis (hyperplastic polyposis) is character-
ized by multiple polyps with serrated architecture in the
colorectum. While patients with serrated polyposis are
known to be at increased risk of colorectal cancer
(CRC) and possibly extracolonic cancers, cancer risks
for their relatives have not been widely explored. The
a i mo ft h i ss t u d yw a st oe s t i m a t et h er i s k so fC R Ca n d
extracolonic cancers for relat i v e so fp a t i e n t sw i t hs e r -
rated polyposis.
Methods
A cohort of the 1,639 first- and second-degree relatives
of 100 index patients with serrated polyposis recruited
regardless of a family history of polyps or cancer from
genetic clinics in Australia, New Zealand, Canada and
the USA, were retrospectively analysed to estimate the
country-, age- and sex-specific standardized incidence
ratios (SIRs) for relatives compared with the general
population.
Results
A total of 102 CRCs were observed in first- and second-
relatives (SIR 2.25, 95% confidence interval, CI 1.75–
2.93; P<0.001), with 54 in first-degree relatives (SIR
5.16, 95% CI 3.70–7.30; P<0.001) and 48 in second-
degree relatives (SIR 1.38, 95% CI 1.01–1.91; P=0.04).
The SIR of CRC for relatives was greater when index
cases were diagnosed under age 50 (P=0.04). Six
pancreatic cancers were observed in first-degree relatives
(SIR 3.64, 95% CI 1.70–9.21; P=0.003). There was no
evidence of increased risk for cancer of the stomach,
brain, breast or prostate.
Conclusions
Our finding that relatives of serrated polyposis patients
are at significantly increased risk of colorectal and pan-
creatic cancer, adds to the accumulating evidence that
serrated polyposis has an inherited component.
Author details
1Centre for MEGA Epidemiology, School of Population Health, University of
Melbourne, Carlton, VIC 3053, Australia.
2Familial Cancer Laboratory,
Queensland Institute of Medical Research, Herston QLD 4006, Australia.
3School of Medicine, University of Queensland, Herston QLD 4006, Australia.
4Division of Human Genetics, Department of Internal Medicine,
Comprehensive Cancer Center, The Ohio State University, Columbus, OH
43221, USA.
5Envoi Pathology, Herston, Q4006, Australia.
6Department of
Molecular and Cellular Pathology, University of Queensland, Herston, Q4006,
Australia.
7Department of Gastroenterology, Middlemore Hospital, Auckland,
New Zealand.
8New Zealand Familial Gastrointestinal Cancer Registry,
Auckland Hospital, New Zealand.
Published: 12 April 2012
doi:10.1186/1897-4287-10-S2-A21
Cite this article as: Win et al.: A study of cancer risks in relatives of
patients with serrated polyposis. Hereditary Cancer in Clinical Practice 2012
10(Suppl 2):A21.
† Contributed equally
2Familial Cancer Laboratory, Queensland Institute of Medical Research,
Herston QLD 4006, Australia
Full list of author information is available at the end of the article
Win et al. Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A21
http://www.hccpjournal.com/content/10/S2/A21
© 2012 Win et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.